USFDA backs half-dose Moderna booster for at-risk adults

Washington: A group of advisors to the US Food and Drug Administration (USFDA ) have voted unanimously recommending Moderna's Covid booster shot for people at risk. The Food and Drug Administration's Vaccines and Related Biological Products Advisory Committee met on Thursday to discuss data on the safety and effectiveness of Moderna booster shots in adults.

It allowed Moderna to supply 3rd doses of its vaccine to people who had their 2nd doses at least 6 months ago and are over 65, have underlying health conditions, or whose jobs put them at high risk of contracting severe Covid-19. All 19 voting members voted in favour, according to reports. The initial Moderna vaccination consists of two 100-microgram shots, but Moderna has said that a single 50-microgram shot should be enough for a booster.

The FDA's final decision will be handed to the US Centers for Disease Control and Prevention and its vaccine advisory committee, which will then make their own decision. The CDC's next vaccine advisory meeting is scheduled for October 20-21 where it is expected to discuss the boosters.

mRNA booster dose generates stronger antibody response after J&J shot: Report

Covid infection during pregnancy impacts foetus immunity: Study

Covid pandemic is not over, people should not lower their guard: AIIMS Director

 

- Sponsored Advert -

Most Popular

- Sponsored Advert -